Neogen
- In Vitro and In Vivo Diagnostic Substances
- Lansing, Michigan
Compensation history
Top executives at Neogen received an average of $820K per person in annual compensation from 2008 to 2022.
Average pay of disclosed executives at Neogen
By year
- 2022
JA$4MJohn E. AdentChief Executive Officer & PresidentSQ$2MSteven J. QuinlanVice President & Chief Financial OfficerDJ$1MDouglas E. JonesVice President & Chief Operating OfficerJL$1MJason W. LillyVice President, International BusinessJH$799KJerome L. HagedornVice President, North American Operations- 2021
JA$3MJohn E. AdentChief Executive Officer & PresidentSQ$877KSteven J. QuinlanVice President & Chief Financial OfficerJL$752KJason W. LillyVice President, International BusinessDJ$649KDouglas E. JonesVice President & Chief Operating OfficerJH$581KJerome L. HagedornVice President, North American Operations
Executives
We found 12 executives who work or worked at Neogen.
John Adent
Neogen
Chief Executive Officer
Steven Quinlan
Neogen
Chief Financial Officer
Douglas Jones
Neogen
Chief Operating Officer
Jason Lilly
Neogen
Vice President, International Business
Jerome Hagedorn
Neogen
Vice President, North American Operations
Terri Morrical
Neogen
Vice President, Animal Safety
James Herbert
Neogen
Chairman
Richard Calk
Neogen
Chief Operating Officer
News
About Neogen
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryIn Vitro and In Vivo Diagnostic Substances
- Address620 Lesher Place, Lansing, Michigan 48912
- Phone5173729200
- Fiscal year endMay 31
Source: SEC filings on August 30, 2022, August 31, 2020, August 30, 2017, August 29, 2014, and September 1, 2010.